Cymat Technologies Stock Today

CYM Stock  CAD 0.14  0.02  12.50%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 88

 
High
 
Low
Very High
Cymat Technologies is selling for under 0.14 as of the 23rd of July 2024; that is 12.5% down since the beginning of the trading day. The stock's lowest day price was 0.14. Cymat Technologies has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Cymat Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of June 2024 and ending today, the 23rd of July 2024. Click here to learn more.
Business Domain
Capital Goods
Category
Industrials
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. It also provides architectural materials under the Alusion brand name and automotive and blast mitigation products under the SmartMetal brand name. The company has 65.69 M outstanding shares of which 13.08 K shares are currently shorted by private and institutional investors with about 0.43 days to cover all short positions. More on Cymat Technologies

Moving against Cymat Stock

  0.59NVDA NVIDIA CDR SplitPairCorr
  0.57META Meta Platforms CDRPairCorr
  0.54MSFT Microsoft Corp CDRPairCorr
  0.53AAPL Apple Inc CDRPairCorr
  0.48AMZN Amazon CDRPairCorr
  0.48WMT Walmart Inc CDRPairCorr

Cymat Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cymat Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cymat Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Executive CEOP MBA
Business ConcentrationIndustrial Machinery & Supplies & Components, Metal Fabrication, Industrials, Industrials, Machinery, Metal Fabrication, Industrials (View all Sectors)
Cymat Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cymat Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Cymat Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cymat Technologies' financial leverage. It provides some insight into what part of Cymat Technologies' total assets is financed by creditors.
Liquidity
Cymat Technologies cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Cymat Technologies has accumulated 2.28 M in total debt. Cymat Technologies has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Cymat Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Cymat Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cymat Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cymat to invest in growth at high rates of return. When we think about Cymat Technologies' use of debt, we should always consider it together with cash and equity.

Total Cash From Operating Activities

(2.97 Million)
Cymat Technologies (CYM) is traded on TSX Venture Exchange in Canada and employs 6 people. Cymat Technologies is listed under Industrial Machinery & Supplies & Components category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cymat Technologies's market, we take the total number of its shares issued and multiply it by Cymat Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cymat Technologies classifies itself under Machinery sector and is part of Industrials industry. The entity has 65.69 M outstanding shares of which 13.08 K shares are currently shorted by private and institutional investors with about 0.43 days to cover all short positions. Cymat Technologies has accumulated about 181.66 K in cash with (2.46 M) of positive cash flow from operations.
Check Cymat Technologies Probability Of Bankruptcy
Ownership Allocation
Cymat Technologies holds a total of 65.69 Million outstanding shares. Almost 99.0 percent of Cymat Technologies outstanding shares are held by general public with 1.38 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cymat Ownership Details

Cymat Technologies Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cymat Technologies market risk premium is the additional return an investor will receive from holding Cymat Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cymat Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cymat Technologies' alpha and beta are two of the key measurements used to evaluate Cymat Technologies' performance over the market, the standard measures of volatility play an important role as well.

Cymat Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cymat Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Additional Tools for Cymat Stock Analysis

When running Cymat Technologies' price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.